1. Home
  2. AVDL vs NAK Comparison

AVDL vs NAK Comparison

Compare AVDL & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • NAK
  • Stock Information
  • Founded
  • AVDL 2015
  • NAK 1983
  • Country
  • AVDL Ireland
  • NAK Canada
  • Employees
  • AVDL N/A
  • NAK N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • NAK Precious Metals
  • Sector
  • AVDL Health Care
  • NAK Basic Materials
  • Exchange
  • AVDL Nasdaq
  • NAK Nasdaq
  • Market Cap
  • AVDL 784.6M
  • NAK 689.4M
  • IPO Year
  • AVDL 1996
  • NAK 2002
  • Fundamental
  • Price
  • AVDL $9.18
  • NAK $1.35
  • Analyst Decision
  • AVDL Strong Buy
  • NAK Strong Buy
  • Analyst Count
  • AVDL 6
  • NAK 1
  • Target Price
  • AVDL $18.17
  • NAK $1.30
  • AVG Volume (30 Days)
  • AVDL 1.3M
  • NAK 7.5M
  • Earning Date
  • AVDL 08-07-2025
  • NAK 08-14-2025
  • Dividend Yield
  • AVDL N/A
  • NAK N/A
  • EPS Growth
  • AVDL N/A
  • NAK N/A
  • EPS
  • AVDL N/A
  • NAK N/A
  • Revenue
  • AVDL $194,450,000.00
  • NAK N/A
  • Revenue This Year
  • AVDL $56.88
  • NAK N/A
  • Revenue Next Year
  • AVDL $29.81
  • NAK N/A
  • P/E Ratio
  • AVDL N/A
  • NAK N/A
  • Revenue Growth
  • AVDL 252.64
  • NAK N/A
  • 52 Week Low
  • AVDL $6.38
  • NAK $0.27
  • 52 Week High
  • AVDL $17.30
  • NAK $1.43
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 47.63
  • NAK 63.31
  • Support Level
  • AVDL $9.10
  • NAK $1.15
  • Resistance Level
  • AVDL $9.76
  • NAK $1.43
  • Average True Range (ATR)
  • AVDL 0.47
  • NAK 0.10
  • MACD
  • AVDL -0.08
  • NAK 0.01
  • Stochastic Oscillator
  • AVDL 14.29
  • NAK 76.39

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About NAK Northern Dynasty Minerals Ltd.

Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.

Share on Social Networks: